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Salt-free fractionation of 
complex isomeric mixtures 
of glycosaminoglycan 
oligosaccharides compatible with 
eSi-MS and microarray analysis
Hao Liu1, Apoorva Joshi2,3, pradeep chopra3, Lin Liu  3, Geert-Jan Boons  2,3,4 & 
Joshua S. Sharp1*
Heparin and heparan sulfate (Hp/HS) are linear complex glycosaminoglycans which are involved in 
diverse biological processes. The structural complexity brings difficulties in separation, making the 
study of structure-function relationships challenging. Here we present a separation method for Hp/HS 
oligosaccharide fractionation with cross-compatible solvent and conditions, combining size exclusion 
chromatography (Sec), ion-pair reversed phase chromatography (ipRp), and hydrophilic interaction 
chromatography (HiLic) as three orthogonal separation methods that do not require desalting 
or extensive sample handling. With this method, the final eluent is suitable for structure-function 
relationship studies, including tandem mass spectrometry and microarray printing. our data indicate 
that high resolution is achieved on both ipRp and HiLic for Hp/HS isomers. in addition, the fractions 
co-eluted in ipRp could be further separated by HiLic, with both separation dimensions capable of 
resolving some isomeric oligosaccharides. We demonstrate this method using both unpurified reaction 
products from isomeric synthetic hexasaccharides and an octasaccharide fraction from enoxaparin, 
identifying isomers resolved by this multi-dimensional separation method. We demonstrate both 
structural analysis by MS, as well as functional analysis by microarray printing and screening using a 
prototypical Hp/HS binding protein: basic-fibroblast growth factor (FGF2). Collectively, this method 
provides a strategy for efficient Hp/HS structure-function characterization.
Heparin and heparan sulfate (Hp/HS) are glycosaminoglycans (GAGs), highly anionic unbranched polysaccha-
rides found on the surface of essentially all mammalian cells. Hp/HS consist of a repeating disaccharide structure 
either β-D-glucuronic or α-L-iduronic acid (GlcA and IdoA, respectively) and α-D-N-acetyl-D-glucosamine 
(GlcNAc), all connected by 1 → 4 linkages1. As a part of biosynthesis, monosaccharides can be differentially N- 
and O-sulfated after polymerization. The GlcA can be epimerized to IdoA and can be 2-O-sulfated, while the 
GlcNAc can be deacetylated (usually followed by N-sulfation) and/or O-sulfated at the 6- and/or 3-position. 
Since these modifications are incomplete and untemplated, there is enormous structural heterogeneity in Hp/
HS chains, including many isomeric structures with widely varying and dynamic compositions2. Different cell 
types will often display different HS structures, and these structures can change as part of the cell’s physiological 
response3. This structural diversity mediates a wide range of protein-GAG interactions of varying specificity 
and affinity. Hp/HS have been involved in a wide and growing array of physiological and pathophysiological 
processes, usually mediated through interactions between proteins and a subset of Hp/HS structures4–6. While 
the importance of oligosaccharide structure has been established in many functions of Hp/HS, understanding 
the structures that underlie any of the various functions is highly challenging. Two technologies that have been 
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applied with considerable success in understanding Hp/HS structure-function relationships are mass spectrom-
etry (MS)7,8 and Hp/HS microarrays9,10. However, the vast diversity, myriad isomeric structures, and difficulties 
in separation make the application of these tools towards Hp/HS oligosaccharides very challenging. The vast 
diversity of potential structures (5.3 million octasaccharides) makes complete coverage by synthetic methods 
impractical11. Therefore, the need for efficient separation technique prior to MS or microarray printing that is 
readily compatible with these techniques is clear12,13.
Low molecular weight heparin (LMWH) is a partially depolymerized product of heparin. In the U.S.A., the 
most widely used LMWH is enoxaparin sodium, which is generated by β-elimination of heparin14. The majority 
of the depolymerization products have a 4,5-unsaturated dehydro-uronic acid residue (ΔUA) at the non-reducing 
end, which can be detected at 232 nm by a UV detector15. Enoxaparin sodium is a good model for the study of 
separation and characterization of Hp/HS with high-performance liquid chromatography (HPLC). Normally, size 
exclusion chromatography (SEC) is the first separation method following partial depolymerization of the Hp/HS 
polysaccharide16. Most methods of Hp/HS depolymerization cleave to the non-reducing end of the uronic acid, 
resulting in oligosaccharide products that differ by a disaccharide unit in length and can be separated by SEC 
based on the oligosaccharide length17. A common follow-up separation is a charge-based separation, strong anion 
exchange chromatography (SAX), which has a high resolving power for Hp/HS fractionation18. However, the high 
concentration of sodium chloride (normally 1.0 M) used in SAX makes it incompatible with MS or other forms 
of chromatography that use organic solvents19. Thus the isolated components after SAX must be desalted prior to 
MS or further separation, causing sample loss compared to the limited sample amount.
Ion-pair reversed phase chromatography (IPRP) is another powerful method for Hp/HS fractionation with 
the addition of ion-pairing agents, such as pentylamine20 or tributylamine21. Compared with SAX, IPRP is more 
easily coupled with other separation methods and MS. Hyphenation of IPRP with SEC and time of flight mass 
spectrometry have greatly improved separation and provided more complete and important structural informa-
tion of low molecular weight heparin (LMWH)22. But the ion-pair agents will easily induce in-source contamina-
tion and cause signal suppression when coupled with MS13. Some IPRP agents can also interfere with microarray 
immobilization schemes23. Reverse-phase chromatography without the use of strong ion pairing reagents (RP) 
has also shown strong separation ability for heavily derivatized chondroitin sulfate isomers and heparan sul-
fate24,25, but the derivatization process leaves the oligosaccharides in non-native conditions not suitable for further 
functional analysis. Thus a more MS- and microarray-friendly orthogonal separation method for native oligosac-
charides is preferred to couple with IPRP.
Hp/HS are very hydrophilic with several polar groups, like sulfates, carboxylates, and hydroxyls. Hydrophilic 
interaction chromatography (HILIC) has been widely used for the chondroitin sulfate (CS), dermatan sulfate (DS), 
and Hp/HS separation26–28. Since HILIC requires only volatile mobile phase components and a pH range readily 
compatible with LC-MS analysis, it is particularly useful for sample cleanup prior to MS in order to provide further 
detailed structural analysis29. The orthogonality of IPRP and HILIC separation has been illustrated for N-linked 
glycans, suggesting the potential power of this hyphenation into a multi-dimensional LC scheme for Hp/HS30.
The structural variability of Hp/HS is responsible for interactions between Hp/HS and a wide variety of 
proteins31. The fibroblast growth factors (FGFs) are the most thoroughly studied proteins, which bind to the 
extracellular matrix by interacting with Hp/HS32,33. Tetra- and hexasaccharides are sufficient to bind FGF2 with 
high affinity34. The 2-O-sulfate iduronate and the N-sulfate of glucosamine are critical motifs for FGF2 binding. 
Carbohydrate microarrays are powerful high-throughput screening platforms to discover Hp/HS-proteins inter-
actions35. The use of microarrays of fractionated Hp/HS will substantially improve the understanding of Hp/
HS-protein interactions.
Here we present a separation method for heparin/HS oligosaccharide fractionation (Fig. 1) with solvent and sepa-
ration conditions that are both readily cross-compatible, as well as a final eluent that is amenable to both electrospray 
(ESI)-MS and microarray immobilization. This method uses SEC, followed by pentylamine/acetic acid IPRP chro-
matography, and ending with amide-HILIC. These hyphenated HPLC separations increase resolving power, bridge 
Hp/HS MS structural analysis and microarray functional studies, and are readily compatible with online or offline 
ESI-MS. Our data highlights the advantages of SEC-IPRP-HILIC for separation and purification of complex mixtures 
of Hp/HS, establishing this methodology as a useful tool for efficient and high-resolution Hp/HS fractionation.
Results
the structural complexity of Hp/HS is preserved during AeAB conjugation. To optimize the 
LMWH sample for both UV detection and microarray immobilization, we used 2-Amino-N-(2-aminoethyl) 
benzamide (AEAB) as a reducing-end tag36. In order to ensure we preserve the structural complexity of Hp/HS 
during AEAB conjugation, we employed the Hp disaccharide standard II-S to develop optimized labeling condi-
tions and validate the chemo-selectivity under the optimized conditions. Hp disaccharide II-S AEAB conjugate 
was prepared under various amounts of acetic acid and analyzed by HILIC LC-MS. As the amount of acetic acid 
increased from 10% to 40%, the main product was shifted from conjugation through the aliphatic amine (IIS-
AEAB1) to conjugation through the arylamine (IIS-AEAB2, Fig. 2). At lower pH, the aliphatic amine was proto-
nated and its nucleophilicity would decrease significantly, leaving the unprotonated arylamine to react with the 
reducing end of heparin disaccharide II-S to form II-S-AEAB2 conjugate. Therefore, a selective AEAB conjugate 
is formed with 40% acetic acid, leaving the aliphatic amine free for use in microarray immobilization chemistry. 
To further confirm the selectivity of the reaction, the synthesized hexasaccharide isomers were labeled under the 
optimized conditions. The results from HILIC-MS showed that there was only one conjugate LC peak for each 
isomer under 40% acetic acid (Fig. S1). This indicated that the conjugation between the aromatic amine and the 
reducing end of the sugar was the only detectable product at 40% acetic acid derivatization conditions, excluding 
the possibilities of introducing isomers during the reductive amination reaction.
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Validation of multi-dimensional separation method with synthetic hexasaccharides. We 
obtained three synthetic hexasaccharides in an unpurified state to evaluate the multi-dimensional separa-
tion method, focusing on the separation of isomeric hexasaccharides in a moderately complex background. 
Figure 1. Multi-dimensional separation workflow. Data shown are taken from this study to represent the 
value of each step. (A) SEC separation of the partially depolymerized Hp/HS, enoxaparin sodium; (B) chemo-
selective reductive amination of one SEC fraction (dp8) with AEAB; (C) IPRP separation of AEAB-labeled 
oligosaccharide SEC fraction (dp8); IPRP fractions could be either analyzed by (D) online HILIC LC/MS (IPRP 
fraction RT 35 to 36 min shown); or (E) separated by offline HILIC with fractions collected (IPRP fraction RT 
36.8 to 38 min shown); (F) microarray immobilization of HILIC fractions and protein binding affinity assay 
(IPRP and HILIC fraction identities shown in Table S1).
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The expected synthetic structure of U-H-1 is ∆4,5UA-GlcNS6S-GlcA-GlcNS6S3S-IdoA2S-GlcNS6S; U-H-2 
is ∆4,5UA-GlcNS6S-IdoA2S-GlcNS3S-IdoA2S-GlcNS6S; U-H-3 is ∆4,5UA-GlcNAc6S-GlcA-GlcNAc6S3S-I
doA2S-GlcNAc6S. Each hexasaccharide was first characterized by amide-HILIC LC-MS and a complex back-
ground was detected due to the partial product GAGs in the reaction (Figs S2–S4). The synthetic hexamers were 
AEAB-labeled with 40% acetic acid, the optimized condition as described above. These AEAB-labeled synthetic 
hexasaccharide products were separately injected onto the C18 column with ion-pairing agents so that the reten-
tion times (RTs) of three labeled hexaccharides could be confirmed (Fig. S5), with the UV trace-based assign-
ments confirmed by HILIC-MS as described below. U-H-3-AEAB (a labeled hexasaccharide with five sulfate 
groups and three acetyl groups) eluted between 19 min and 20 min. Two isomeric hexasaccharides with eight 
sulfate groups and no acetyl group, U-H-1-AEAB and U-H-2-AEAB, were separated by IPRP. U-H-2-AEAB 
eluted between 22 min and 23 min while U-H-1-AEAB eluted between 25 min and 26 min. This overall elution 
pattern was consistent with IPRP elution order, where lower sulfated oligosaccharides elute earlier. To validate the 
multi-dimensional separation method, the mixture of three labeled synthetic hexasaccharide products was ini-
tially separated by IPRP (Fig. 3), and fractions of isomeric hexamers were collected and subsequently separated by 
online amide-HILIC LC-MS. LC-MS displayed two peaks with an [M -4H]4− ion of m/z 452.5 corresponding to 
the [1, 2, 3, 8, 0, 1] (labeled isomeric composition) from two IPRP fractions (RT 22 to 23 min & RT 25 to 26 min) 
Figure 2. Chemo-selectivity of reductive amination of Hp/HS with AEAB. (A) Scheme of AEAB reductive 
amination. The difference in pKa between the aromatic amine and the aliphatic amine achieves selective 
reactivity by controlling the reaction pH. (B) Extracted ion chromatogram of Hp disaccharide II-S: AEAB 
conjugate after reaction in different concentrations of acetic acid (v/v). The earlier eluting peak represents 
conjugation of AEAB through the aliphatic amine, with the desired conjugation product through the aromatic 
amine eluting later.
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(Fig. 4). In the extracted ion chromatograms (EICs), one isomer in IPRP RT 22 to 23 min fraction was eluted at 
27.1 min on amide-HILIC, which was U-H-2-AEAB. The other isomer in IPRP RT 25 to 26 min fraction was 
eluted at 28.0 min on amide-HILIC, which was U-H-1-AEAB. Both isomers were co-eluted on IPRP from 23 to 
24 min. The AEAB labeled isomers were not only separated by IPRP (RT 22 to 23 min vs. 25 to 26 min) but LC-MS 
of the IPRP fraction collected in the valley of the two unresolved isomeric peaks (RT 23 to 24 min) displayed two 
resolved peaks on HILIC-MS. This result demonstrated the ability of HILIC to separate isomers with distinct 
sulfate positions under the conditions used here. Overall, IPRP coupled with amide-HILIC not only exchanges 
solvent to more compatible volatile one for MS sequencing, but also provides high-resolution separations in each 
dimension for Hp/HS oligosaccharides.
Sec-ipRp-HiLic separation of enoxaparin sodium. To further evaluate the multi-dimensional sep-
aration method, we applied the method to a more complex starting material, enoxaparin sodium. Enoxaparin 
sodium is a degraded product of heparin; hence it is a good model for highly complex sulfated oligosaccharides 
derived from natural sources. Due to the multi-dimensional structural complexity of enoxaparin sodium (chain 
length, sulfate number, and sulfation pattern), size exclusion chromatography was introduced as the first dimen-
sion separation to lower the complexity of size. We employed a size-defined octasaccharide fraction to further 
validate the multi-dimensional separation method.
The octasaccharide SEC fraction of enoxaparin sodium was derivatized with AEAB under optimized condi-
tions and then subjected to IPRP chromatography (Fig. 5). Four diverse fractions from the IPRP chromatogram 
were selected and separately injected onto the amide-HILIC column. The top four possible octasaccharide com-
positions in each IPRP fraction were analyzed by GlycoWorkbench and listed in Table 1. For the same octasac-
charide compositions (e.g. [1, 3, 4, 8, 1, 1]), the signal was detected in two disparate IPRP fractions (35 to 36 min 
and 40 to 41 min), which also had different retention times on amide-HILIC (27.84 min vs. 19.69 min) (Fig. 6). 
Interestingly, the huge difference in retention times (ΔRT = 5 min on IPRP and ΔRT = 8 min on amide-HILIC) 
indicated that a very high resolution was achieved with the multi-dimensional separation method. Similar iso-
meric separations could also be found for [1, 3, 4, 7, 1, 1] and [1, 3, 4, 9, 1, 1] (Figs S6 through S7). Thus, oligosac-
charide composition analysis demonstrated that the powerful multi-dimensional separation method was able to 
resolve complex isomeric structures, especially sulfate positional isomers.
Although IPRP itself could separate simple isomers, it may not be sufficient for complex mixtures like Hp/HS. 
In order to examine the possible advantages of adding in an amide-HILIC dimension, we examined extracted 
ion chromatograms of various compositions from the surveyed IPRP fractions on HILIC LC-MS as shown in 
Figs 6 and 7 and Supplementary Information (Figs S8 through S10). For some compositions such as [1, 3, 4, 8, 
2, 1], two isomers co-eluted in IPRP (both in 35–36 min fraction) but were separated on HILIC (26.8 min vs. 
32.4 min) (Fig. 7). This indicated that the multi-dimensional separation method could provide higher resolution 
than the one-dimensional separation method for Hp/HS. Additionally, the eluent is completely volatile, making 
buffer exchange convenient with very little sample loss. Overall, the data validated that the multi-dimensional 
separation method had a high resolution for Hp/HS, and effectively eliminated ion pairing reagents from the 
buffer simultaneously.
the application of the multi-dimensional separation method for microarray functional studies. 
As a further test of the application of the multi-dimensional separation method, we probed fractions for binding 
to FGF2. All FGFs have a high affinity for Hp/HS and the affinity of FGF is modulated by different Hp/HS struc-
tures37. Therefore, this assay would identify which highly enriched fractions had a higher affinity to FGF2 and 
demonstrate the compatibility of the multi-dimensional separation method with amine-mediated microarray 
immobilization.
Figure 3. IPRP chromatogram of AEAB labeled synthetic hexasaccharide mixture with UV detection at (blue) 
232 nm and (orange) 260 nm. After labeling with AEAB, these synthetic hexasaccharides were separated on 
IPRP. Peaks were initially assigned based on the elution time of the major peak in the individual synthetic 
reaction product (Supplementary Information Fig. S5). HILIC LC-MS data from fractions shown in black, red, 
and green are shown in Fig. 4.
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We employed the multi-dimensional separation method described above to lower the structural complex-
ity gradually and constructed Hp/HS oligosaccharide fraction microarrays for functional study, starting with 
the octasaccharide fraction from SEC. More than 40 fractions were collected from the IPRP run (starting from 
Figure 4. The extracted ion chromatograms of [M -4H]4− ion corresponding to AEAB-labeled [1, 2, 3, 8, 0, 
1] from IPRP fractions. The EICs have shown that the derivatized hexasaccharide composition [1, 2, 3, 8, 0, 1] 
collected from IPRP in the 22 to 23 min fraction (top) eluted from the HILIC column around 27.1 min, while 
the same composition from the IPRP 25 to 26 min fraction (bottom) eluted around 28.0 min on HILIC. The 
IPRP 23 to 24 min fraction contains the shoulders of both isomer peaks in the IPRP chromatogram, and by 
HILIC (middle) both the 27.1 and the 28 min peak are partially resolved.
Figure 5. Separation of AEAB labeled enoxaparin octasaccharides using IPRP detected using 232 nm 
(blue trace) and 260 nm (orange trace) wavelengths. The heterogeneous enoxaparin octasaccharide fraction 
separated into many poorly-resolved peaks across the elution window. The four fractions highlighted in the 
chromatogram were collected for further HILIC separation and MS analysis as examples.
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retention time 24 min to 77 min). HILIC separation was performed for each IPRP fraction, with each peak col-
lected as a fraction and lyophilized. Using AEAB absorbance to quantify oligosaccharide concentration (using a 
calibration curve based on AEAB-labeled Hp disaccharide), 5nmol of each eluent fraction was aliquoted out and 
diluted in appropriate buffer to yield a printing concentration of 100 μM38. Together with three controls [AEAB 
labeled enoxaparin sodium octasaccharides (in duplicate), and synthetic octasaccharide], 129 highly enriched 
oligosaccharide fractions were printed in replicates of 6 on NHS-ester activated glass slides, generating a series 
of Hp/HS octasaccharide microarrays. Through multi-dimensional separations, some octasaccharide fractions 
(Sample No. 52, 58, 65, and 85) had a higher affinity to FGF2 with higher fluorescence signal while some octasac-
charide fractions (Sample No. 53, 55, 60, and 70) had low affinity to FGF2 with lower fluorescence signal (Fig. 8, 
Fig. S11 and Table S1). Analysis of FGF2 binding versus retention time by IPRP and HILIC reveals a strong cor-
relation between HILIC retention and FGF2 binding (Fig. 9). Previous work by Zaia and coworkers have shown 
IPRP fraction (Retention Time) Oligosaccharide composition†
27–28 min
[1, 3, 4, 6, 1, 1]
[1, 3, 4, 6, 2, 1]
[1, 3, 4, 7, 1, 1]
[1, 3, 4, 8, 0, 1]
35–36 min
[1, 3, 4, 7, 1, 1]
[1, 3, 4, 8, 1, 1]
[1, 3, 4, 8, 2, 1]
[1, 3, 4, 9, 1, 1]
40–41 min
[1, 3, 4, 8, 1, 1]
[1, 3, 4, 9, 1, 1]
[1, 3, 4, 10, 1, 1]
[1, 3, 4, 10, 0, 1]
58–61 min
[1, 3, 4, 11, 0, 1]
[1, 3, 4, 12, 0, 1]
Table 1. Most abundant compositions of AEAB labeled octasaccharides from multi-dimensional separation. 
†Oligosaccharide compositions are given as [∆HexA, HexA, GlcN, SO3, Ac, AEAB].
Figure 6. The HILIC EICs of [M -4H]4− ion corresponding to [1, 3, 4, 8, 1, 1] from IPRP fractions. (A) In the 
IPRP 35 to 36 min fraction, this composition eluted at 27.8 min. (B) In the IPRP 40–41 min fraction, a different 
structure with this composition is eluted at 19.7 min. Oligosaccharide compositions are given as [∆HexA, 
HexA, GlcN, SO3, Ac, AEAB].
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that amide-HILIC retention time is dominated by acetyl and sulfate composition for Hp/HS oligosaccharides 
of a given size39, indicating that FGF2 binding increases as sulfate content increases. This is consistent with pre-
vious microarray results using synthetic oligosaccharides that showed that FGF2 binds all highly sulfated GAG 
tetrasaccharides well, while intermediately sulfated structures showed a clear structure-function relationship40, 
and is consistent with other FGF2 binding structure-function studies showing preference for high sulfation and 
indicating the importance of 2-O-sulfation and N-sulfation to FGF2 binding41–44.
Figure 7. The EICs of the top four octasaccharide compositions from the IPRP 35–36 min fraction. The 
octasaccharides, which are not separated by IPRP, are resolved by HILIC, including two clearly separated [1, 
3, 4, 8, 2, 1] isomers, illustrating orthogonality between HILIC and IPRP chromatography. Oligosaccharide 
compositions are given as [∆HexA, HexA, GlcN, SO3, Ac, AEAB].
Figure 8. FGF2-binding assay on Hp/HS octasaccharide-AEAB microarray. Each fraction is printed in 
replicates of 6 in a single block with droplet volume around 400 pL. Fractions from the multi-dimensional 
separation method are directly applicable to microarray study. Based on the fluorescent intensity of each 
spot, it indicates that each fraction has different binding affinities to FGF2. Fractions from No. 1 to No. 126 
were eluents from the multi-dimensional separation method. Fractions No. 127 & 128 were unfractionated 
octasaccharide. Fraction No. 129 was synthetic octasaccharide as a positive control. An image of the microarray 
is in Supplementary Information Fig. S11. Detailed information of each fraction is listed in Table S1.
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Discussion
Although Hp/HS influence numerous physiological and pathophysiological processes, their high degree of size 
polydispersity and sequence microheterogeneity make the structure-function characterization challenging. In 
most modern cases, structural analysis is limited to compositional analysis, with oligosaccharide sequences 
rarely addressed from complex mixtures. Here we demonstrate a three-dimensional LC separation method, 
SEC-IPRP-HILIC, that is applied for the efficient analysis of Hp/HS with high resolution separation of isomeric 
sequences, compatibility with both on-line and off-line MS structural analysis and microarray functional analysis.
We have shown that IPRP and HILIC offer orthogonal selectivity with a resolution that can, at least in some 
cases, separate positional isomers that differ by the site of modification and possibly uronic acid stereochemistry 
(which was not directly probed in this study), with an overview of the contribution of each step demonstrated 
in Fig. 1. Although IPRP itself could separate Hp/HS isomers, our data demonstrate incomplete separation of 
some isomers, indicating that extra separation is needed to resolve more detailed structural information in Hp/
HS. For the first time, clean HILIC separation of isomeric Hp oligosaccharides is demonstrated, as shown in 
Fig. 6 for composition [1, 3, 4, 8, 1, 1] and octasaccharide compositions [1, 3, 4, 7, 1, 1] and [1, 3, 4, 9, 1, 1] in 
Supplementary Information (Figs S6 and S7) among others. Each separation dimension adds resolution to the 
overall separation, in addition to HILIC serving as a desalting step to remove ion pairing reagents from IPRP 
fractions.
We also demonstrate the compatibility of the multi-dimensional separation method to glycan microarray 
analysis. The fractions from HILIC are directly compatible with microarray immobilization. Ammonium for-
mate, acetonitrile and water used in our HILIC method are volatile and does not interfere with the immobilization 
method and allows buffer exchange by evaporation or lyophilization, with very little sample loss. Glycan microar-
rays permit the study of specific Hp/HS-binding proteins quantitatively even with a very limited amount. AEAB 
incorporates stoichiometrically to oligosaccharides by specific reductive amination to provide both increased 
UV detection sensitivity and a reactive group for immobilization, and only 1 to 2 nmols of AEAB-labeled Hp/HS 
fractions are required to prepare microarrays. Our unfractionated octasaccharide microarray results (Sample No. 
127 & No. 128) showed lower binding than our fractions with highest activity, confirming that multi-dimensional 
separation does not compromise the binding capability of the oligosaccharides. As anticipated, the microarray 
data also display clear diversity in binding affinities of each fraction (Fig. S11 and Table S1), consistent with 
the intermediate structural specificity of FGF2 binding to Hp/HS oligosaccharides45–47. Although Hp/HS sepa-
rated by the multi-dimensional separation method might have similar compositions, both their separation and 
diverse binding affinities indicate that they are structurally and functionally different. It is possible that the unique 
structures or composition motifs binding with FGF2 are separated from unbinding Hp/HS fractions. While 
AEAB-labeling and microarray analysis provide powerful options for structure-function analysis, this method 
will also work for salt-free fractionation of depolymerized oligosaccharides without derivatization of the reducing 
end, so long as the unsaturation at the non-reducing end is present to provide a chromophore or some other LC 
detection method is available.
Overall, this multi-dimensional separation method provides high-resolution separation of Hp/HS and thus 
generates Hp/HS microarrays for functional study with high purity. The ability to perform HILIC-MS directly 
allows investigators to directly couple structural interrogations with functional analysis. Future studies will couple 
this separation method with more detailed Hp/HS structural interrogation methods that determine precise sites 
of sulfation48–50, which are usually lost in MS/MS analysis. In addition, such Hp/HS microarrays will be useful for 
screening more Hp/HS-binding proteins and will permit the discovery of new protein-carbohydrate interactions. 
Thus, this method is invaluable in recognizing complex protein-carbohydrate interactions and is also essential to 
reveal functional Hp/HS structures as novel biomaterials or therapeutics.
Methods
chemicals and reagents. Enoxaparin sodium injection (Winthrop/Sanofi, Bridgewater, NJ, USA) was used 
as provided. 2-amino-N-(2-aminoethyl)-benzamide (AEAB) was purchased from Chem-Impex International 
(Wood Dale, IL, USA). Water was purified by a MilliQ® system (Millipore, Bedford, MA, USA). Ammonium 
formate and sodium cyanoborohydride were purchased from Thermo Fisher Scientific (Waltham, MA, USA). 
Figure 9. Correlation between IPRP retention time, HILIC retention time, and FGF2 binding response by 
microarray analysis at 1 µg/mL, represented by bubble size. A strong correlation between HILIC retention 
time and FGF2 binding is apparent, indicating that FGF2 is binding ligands that are more highly sulfated. No 
correlation between IPRP retention time and FGF2 binding is apparent.
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Glacial acetic acid, dimethyl sulfoxide (DMSO), formic acid, and pentylamine were purchased from Millipore 
Sigma (St. Louis, MO, USA). All chemicals used were at least of analytical grade. Three hexasaccharides with 
unsaturated uronic acid at the non-reducing end were chemically synthesized using modified reported proce-
dures and the reaction products were desalted over a Bio-Gel P-2 column (Bio-Rad, Hercules, CA, USA) with-
out further purification; the detailed synthetic methodology will be reported elsewhere. The expected synthetic 
structure of U-H-1 is ∆4,5UA-GlcNS6S-GlcA-GlcNS6S3S-IdoA2S-GlcNS6S; U-H-2 is ∆4,5UA-GlcNS6S-IdoA2S-
GlcNS3S-IdoA2S-GlcNS6S; U-H-3 is ∆4,5UA-GlcNAc6S-GlcA-GlcNAc6S3S-IdoA2S-GlcNAc6S. Recombinant 
human fibroblast growth factor basic was purchased from R&D Systems, Inc. (Minneapolis, MN, USA). Rabbit 
anti-FGF-2 antibody was purchased from Abcam (Cambridge, MA, USA). Goat anti-rabbit Cy5 antibody was 
purchased from Life Technologies (Carlsbad, CA, USA).
Size exclusion chromatography (Sec). SEC separation was performed on a chromatographic column 
packed with P-10 media (Bio-Rad®, 45–90 µm) and collected by a Frac-920 fraction collector (GE Healthcare 
Life Sciences, Chicago, IL, USA). 100 mg of commercial Enoxaparin Sodium Injection was injected onto the SEC 
column and separated by using 0.5 M ammonium bicarbonate eluent at a flow rate of 0.2 mL/min. GAG oligosac-
charide quantities were measured using a NanoDropTM 2000 spectrophotometer (Thermo Fischer Scientific) at 
a detection wavelength of 232 nm. Fractions from each peak were pooled and evaporated with dry nitrogen gas 
flow.
preparation of AeAB oligosaccharide derivatives. The enoxaparin sodium size-fractionated samples 
were re-dissolved with water and acetic acid. 0.4 M AEAB in DMSO and 1 M sodium cyanoborohydride in DMSO 
were added. The ratio of DMSO and acetic acid was varied with acetic acid contents of 10%, 20%, 30% and 40% 
v/v tested, with 40% acetic acid used as an optimized condition. The mixture was then incubated at 37 °C over-
night and dried with nitrogen gas. The dried sample was resuspended in water/methanol (80:20, v/v). It was ana-
lyzed and purified by HPLC SEC column (4.6 mm × 300 mm, 1.7 µm, Waters) using a Dionex UltiMate 3000 LC 
system (Thermo Fisher Scientific) following the method of Dr. Zaia and coworkers51. Based on high-resolution 
SEC separation of derivatized II-S disaccharide standard, the reductive amination reaction had a yield of ~99% at 
40% acetic acid (data not shown). Fractions were collected with an online auto-sampler and further dried down 
with nitrogen gas. Each synthetic hexasaccharide followed the same protocol.
ion-pair reverse phase chromatography (ipRp). IPRP separations were performed on a Dionex 
UltiMate 3000 LC system (Thermo Fisher Scientific) using a C18 column (150 mm × 2.1 mm, 2.6 µm, Kinetex®, 
Phenomenex), with a UV-visible spectrophotometric detector. Phase A was 95% water and 5% acetonitrile and 
phase B was acetonitrile. The ion-pairing agents were 20 mM pentylamine (PTA) and 20 mM acetic acid. All 
chromatographic separations were monitored at both 232 nm and 260 nm wavelengths. The separation gradient 
started with 10% B for 5 min, ramped to 20% B and held for 10 min, followed a linear gradient from 20% to 29% 
B over 65 min, changed to 50% B over 5 min, washed with 50% B for 25 min, then changed to 10% B over 1 min 
and re-equilibrated for 24 min. The flow rate was 0.1 mL/min. The column temperature was 40 °C. Fractions were 
collected with an online auto-sampler and further dried under the nitrogen gas flow.
Amide hydrophilic interaction chromatography (HiLic). Hydrophilic interaction chromatography 
(HILIC) was performed on a BEH Amide HILIC column (50 mm × 1 mm, 1.7 µm, ACQUITY UPLC® BEH 
Amide, Waters). The flow rate was set to 0.1 mL/min. The gradient for hexasaccharide analysis started with 90% B 
for 5 min, with a linear gradient down to 30% B over 60 min, held at 30% B for 4 min and finally washed with 10% 
B for 10 min and re-equilibrated with 90% B for 10 min. The gradient for octasaccharide analysis started at 75% 
B for 5 min, with a linear gradient from 75% B to 30% B over 60 min, held at 30% B for 4 min and finally washed 
with 10% B for 10 min and re-equilibrated with 75% B for 10 min. Buffer A was 10 mM ammonium formate (pH 
4.4, adjusted with formic acid) and buffer B was 98% acetonitrile with 2% buffer A for online LC-MS analysis. 
Buffer A was 50 mM ammonium formate (pH 4.4, adjusted with formic acid) for microarray fractionation.
online Lc-MS method and MS data analysis. The fractionated samples after IPRP were analyzed by 
LC-MS on a Thermo Orbitrap Fusion Tribrid (Thermo Fisher Scientific) coupled with a Dionex UltiMate 3000 
liquid chromatography (Thermo Fisher Scientific) using a BEH Amide HILIC column (50 mm × 1 mm, 1.7 µm, 
ACQUITY UPLC® BEH Amide, Waters). The oligosaccharides were analyzed in negative ion mode with the ESI 
voltage set to 1.8 kV. Full mass scan range was set to 230–1000 m/z at a resolution of 60000, and the automatic 
gain control (AGC) target was set to 1 × 105 counts. The datasets generated during and/or analysed during the 
current study are available from the corresponding author on reasonable request. GlycoWorkbench software was 
used to interpret the possible compositions of Hp/HS oligosaccharide ion signals. To interpret the MS data with 
GlycoWorkbench, we set searching constraints based on the biosynthetic rules of heparin. The maximum value 
of dehydro-hexuronic acid was set to 1 while the maximum value for hexuronic acid and hexosamine were both 
set to 5. The maximum number of sulfate groups was 24 and the maximum number of acetate groups was 5. The 
reducing end delta mass was selected as a mass value of 163.1 Da for the AEAB label. Compositions are reported 
according to a modified version of the bracketed nomenclature of Dr. Zaia and coworkers [A, B, C, D, E, F], where 
A is the number of dehydro-uronic acid monosaccharides, B is the number of uronic acid monosaccharides, C is 
the number of glucosamine monosaccharides, D is the number of sulfations, E is the number of acetylations, and 
F is the number of AEAB labels in the identified composition51.
Microarray printing, binding assay, and scanning. The arrays were constructed using the guidelines v 
1.0. provided by the Minimum Information for a Glycomics Experiment Project (MIRAGE) as reported here38.
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126 fractions after off-line HILIC separation were printed on NHS-ester activated glass slides (NEXTERION® 
Slide H, Schott Inc.) using a Scienion sciFLEXARRAYER S3 non-contact microarray equipped with a Scienion 
PDC80 nozzle (Scienion Inc.). Individual samples (5 nmols) were dissolved in sodium phosphate buffer (50 µL, 
0.225 M, pH 8.5) at a concentration of 100 µM and were printed in replicates of 6 with spot volume ~ 400 pL, at 
20 °C and 50% humidity. Each slide has 24 subarrays in a 3 × 8 layout. After printing, slides were incubated in a 
humidity chamber for 8 hours and then blocked for one hour with a 5 mM ethanolamine in a Tris buffer (pH 9.0, 
50 mM) at 50 °C. Blocked slides were rinsed with DI water, spun dry, and kept in a desiccator at room temperature 
for future use.
Printed glass slides were incubated with premixed solution of recombinant human fibroblast growth factor 
basic (1.0 to 0.25 µg/mL FGF-2), rabbit anti-FGF-2 antibody (1:300) and goat anti-rabbit Cy5 antibody (1:300) at 
room temperature in the dark. After 1 h, the slide was sequentially washed by dipping in TSM wash buffer (2 min, 
containing 0.05% Tween 20), TSM buffer (2 min) and, water (2 × 2 min), spun dry. The slides were scanned using 
a GenePix 4000B microarray scanner (Molecular Devices) at the appropriate excitation wavelength with a reso-
lution of 5 µm. Various gains and PMT values were employed in the scanning to ensure that all the signals were 
within the linear range of the scanner’s detector and there was no saturation of signals. The image was analyzed 
using GenePix Pro 7 software (version 7.2.29.2, Molecular Devices).
The data was analyzed with our home written Excel macro to provide the results. The highest and the lowest 
value of the total fluorescence intensity of the six replicates spots were removed, and the four values in the middle 
were used to provide the mean value and standard deviation.
Data availability
The data generated and analyzed during the current study are available on request.
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